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Abstract
Background: In mammals the interplay between the peripheral nervous system (PNS) and adipose tissue is widely
unexplored. We have employed mice, which develop an adult onset of obesity due to the lack the neuronal specific
transcription factor Nscl-2 to investigate the interplay between the nervous system and white adipose tissue (WAT).
Methodology: Changes in the architecture and innervation of WAT were compared between wildtype, Nscl22/2, ob/ob
and Nscl22/2//ob/ob mice using morphological methods, immunohistochemistry and flow cytometry. Metabolic
alterations in mutant mice and in isolated cells were investigated under basal and stimulated conditions.
Principal Findings: We found that Nscl-2 mutant mice show a massive reduction of innervation of white epididymal and
paired subcutaneous inguinal fat tissue including sensory and autonomic nerves as demonstrated by peripherin and
neurofilament staining. Reduction of innervation went along with defects in the formation of the microvasculature,
accumulation of cells of the macrophage/preadipocyte lineage, a bimodal distribution of the size of fat cells, and metabolic
defects of isolated adipocytes. Despite a relative insulin resistance of white adipose tissue and isolated Nscl-2 mutant
adipocytes the serum level of insulin in Nscl-2 mutant mice was only slightly increased.
Conclusions: We conclude that the reduction of the innervation and vascularization of WAT in Nscl-2 mutant mice leads to
the increase of preadipocyte/macrophage-like cells, a bimodal distribution of the size of adipocytes in WAT and an altered
metabolic activity of adipocytes.
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Introduction
The regulation of energy balance is controlled by a complex
system that allows the brain to sense and integrate various signals
in order to elicit suitable changes in food intake and energy
expenditure. A failure of the CNS control of food intake will result
in an increase of the mass of WAT of an organism by a
combination of increasing adipocyte cell size and number. The
increase in WAT mass is not only caused by expansion of
adipocytes but also by differentiation of fibroblast-like preadipo-
cytes that are already determined for an adipocyte fate. Preadipose
cell lines and primary cultures of preadipocytes are committed
solely to the adipocyte lineage and differentiate either spontane-
ously or under the influence of adipogenic hormones such as IGF-I
and glucocorticoids into mature adipocytes [1–4]. Adipose tissue is
not only the main energy reservoir of the body but a complex
organ in which adipocytes, connective tissue matrix, nerve tissue,
stromal vascular cells and immune cells function as an integrated
unit. Molecules secreted by adipocytes include adipocytokines, e.g.
leptin, adiponectin, resistin, interleukin 6 (IL-6) but also IGF-1,
adenosine, plasminogen activator inhibitor, and TNF-a. These
factors are essential components of the peripheral signals that
control regulatory processes in the hypothalamus affecting energy
homeostasis and reproduction [5–7].
The majority of pathways that control feeding behavior
converge on the hypothalamus [8] although several ‘‘peripheral’’
anabolic and catabolic hormones act at various sites within the
central nervous system. The integration and interpretation of
incoming signals involves several hypothalamic transcription
factors including the basic helix-loop-helix protein Nscl-2
(Neurological stem cell leukemia). Nscl-2 is also known as Nhlh2
(nescient helix-loop-helix 2) according to the HUGO and NCBI
nomenclature. Nscl-2 and the closely related NSCL-1 are
expressed in large areas of the developing central and peripheral
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paraventricular nucleus (PVN), arcuate nucleus (ARC), and in
neurons of lateral, ventromedial and dorsal medial hypothalamus
of adult mice [11]. Nscl-2 mutant mice show an adult onset of
obesity [12] and infertility, which is at least in part caused by
disrupted migration of developing GnRH-1 neurons [13].
Adolescent Nscl-2 mutant animals show reduced physical activity
while adult obese Nscl-2 mutant mice are characterized by both
increased food intake and reduced voluntary physical activity [14].
Neither NSCL-1 nor Nscl-2 are expressed outside the nervous
system as demonstrated by numerous expression studies and by
the use of LacZ-knock-in reporter mice [10].
So far, the knowledge about a direct control of the metabolic
activity of adipocytes or their differentiation by CNS-derived
signaling pathways is limited [3]. Similarly, no clear correlation
between peripheral innervation and adipocyte differentiation or
metabolic activity has been established and genetic systems to study
such effects were missing. On the other hand, it has been postulated
that sympathetic nerves are involved in the control of lipolysis
[15,16] and it has been shown that sympathetic denervation of
WAT triggers an increase in fat cell number although it is unknown
whether this is due to preadipocyte proliferation or maturation of
existing preadipocytes [17]. The nervous system might also affect
the white adipose tissue indirectly by targeting blood vessels that
influence adipocytes [18]. However, a general link between
peripheral innervation and the degree of microvascularization of
white adipose tissue has not been disclosed yet.
In the current study we have employed Nscl-2 knockout mice to
investigate the interplay between the nervous system and WAT.
We found that Nscl-2 knockout mice show a reduced peripheral
innervation and microvascularization, which correlated with an
accumulation of preadipocyte/macrophage-like cells and hetero-
geneity of adipocyte sizes.
Results
Nscl-2 mutant mice suffer from reduced innervation and
vascularization of WAT
Deletion of Nscl-2 leads to a complex neurological phenotype
that comprises infertility and an adult-onset of obesity. These
defects are most likely the result of malfunctions of the regulatory
network within the CNS, which control genes important to energy
expenditure, and more specifically voluntary physical activity of
animals [14]. We wondered whether disruption of the Nscl-2 gene
did also affect development of the PNS since Nscl-2 is strongly
expressed in the dorsal root ganglia and the autonomic nervous
system [10,19]. For our analysis we concentrated on WAT since
morphological analysis of different tissues revealed pathological
changes in WAT, which were apparent before the animals
became obese (see below). We detected a strong reduction of the
expression of neurofilament, a marker for sensory neurons [20], in
epididymal and subcutaneous adipose tissue of Nscl-2 mutants
(Fig. 1A). Small nerve fibers that are normally easily detected
within the adipose tissue were absent together with a strong
reduction of neurofilament staining within funiculi and larger
nerve fascicles. In the subcutaneous adipose tissue the funiculi of
Nscl-2 (2/2) mice were almost devoid of neurofilament (Fig. 1Aa–
d). We also investigated the presence of unmyelinated fibers in
adipose tissues, which include postganglionic fibers of the
autonomic nervous system (sympathetic and parasympathetic).
Unmyelinated fibers are marked by expression of peripherin while
neurofilament is specifically expressed in myelinated fibers [20].
We found a massive decrease of the number of peripherin-positive
fibers in epididymal and subcutaneous adipose tissue of Nscl-2
mutants at 8, 16 and 24 weeks after birth (Fig. 1Ae, f, Fig. 2).
Normally, neurofilament and peripherin positive axons are
embedded into streets of connective tissue along the capillaries
and recent evidence suggests an intensive crosstalk between the
vascular and the nervous system [21]. Hence, we also wanted to
know whether the reduction of nerve fibers might affect formation
of the microvasculature in adipose tissue of Nscl-2 mutant mice.
Immunohistochemical staining with antibodies against the vascu-
lar markers CD31 and CD34 revealed a strong decrease of
microvasculature formation in Nscl-2 mutant mice (Fig. 1B) both
in subcutaneous and epididymal fat tissue. Quantitative assessment
of the expression of CD34 by Western blot analysis disclosed a
decrease of CD34 expression of 7761% in subcutaneous and of
4162% in epididymal fat tissue (Fig. 1C, D), which corresponded
to the reduced presence of microvasculature observed after
immunohistochemical staining.
Increased expression of leptin precedes obesity in Nscl-2
mutant mice
Since our morphological analysis revealed a reduction of
innervation and vascularization in Nscl-2 well before the mutant
mice became obese we wondered whether Nscl-2 mutant WAT
might also show an aberrant release of adipokines prior to the
abnormal gain of weight. To address this question we first
monitored the increase of body weight in our strain of Nscl-2
mutant mice. We found that Nscl-2 mutant mice show a normal
birth weight and did not gain excessive weight until after puberty.
After puberty, which has been reported for C57 mice to occur
between 4 weeks (vaginal opening) and 8.5 weeks (cyclicity) [22],
body fat increased noticeably (Fig. 3A) eventually resulting in a
body weight of Nscl-2 (2/2) mice that was 34% higher compared
to WT mice (32.6460.63 g versus 24.42 g60.53 g) at the age of
25 weeks (Fig. 3B). This observation corroborated previous reports
[14,23], which were generated using a different strain of Nscl-2
mutant mice. Interestingly, serum concentrations of leptin and
adiponectin in Nscl-2 mutant mice were already significantly
elevated at 8 weeks, at a time when the body weight was not
significantly different between mutant and wildtype animals
(Fig 3C, D). After puberty the leptin level increased further and
reached a peak at 24 weeks (Fig 3C). We also detected a marked
elevation in the serum concentrations of adiponectin and resistin
in 6–8 month old NSLC-2 (2/2) mice (Fig. 4). The high levels of
leptin in Nscl-2 knockout mice suggested that these mice are
resistant to leptin signaling. Indeed, peripherally administration of
leptin with osmotic mini pumps over a time period of 14 days did
not result in a significant reduction of the body weight of Nscl-2
mutants compared to C57Bl/6 controls (data not shown). We
concluded that the increase of serum leptin and adiponectin levels
was caused by changes in the WAT such as decreased innervation
and vascularization that occurred before onset of obesity.
Nscl-2 knockout mice show increased numbers of
preadipocyte/macrophage-like cells and a bimodal
distribution of the size of adipocytes in WAT
Previously, it had been demonstrated that sympathetic dener-
vation of WAT triggers an increase in fat cell number, which
might be due to preadipocyte proliferation or maturation of
existing preadipocytes [17]. We therefore studied more closely the
architecture of white adipose tissue of wildtype, Nscl-2 (2/2) mice
using semithin sections. Additionally we also characterized ob/ob,
and Nscl-2 (2/2)6ob/ob compound mutant mice to study
whether Nscl-2 deficiency changed the fat cell phenotype of the
leptin deficient ob/ob strain. Adipose tissue of wild type and ob/
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like cells per 250 adipocytes while Nscl-2 (2/2) mice showed a 7-
fold increase of cells of the preadipocyte/macrophage-like lineage
in WAT at 6 months of age (F=250.71; dF=3; p,10
24; Fig. 5A).
The arrows in Figure 5C indicate groups of small preadipocyte/
macrophage-like cells between mature adipocytes. To further
characterize this group of small cells with the focus on
identification of preadipocytes we used a combination of
MOMA-2 and F4/80 antibodies. MOMA-2 (macrophage and
monocyte antibody-2) is expressed by macrophages and preadi-
pocytes including the 3T3-L1 preadipocyte cell line while the F4/
80 antibody specifically detects macrophages but not preadipo-
cytes such as 3T3-L1 cells. Hence, the difference between
MOMA-2 and F4/80 positive cells corresponds to adipocyte
precursors [24]. We counted 2 MOMA-2 pos. / F4/80 neg. cells
per 250 adipocytes in WT but 2464 per 250 adipocytes in Nscl-2
(2/2) mice, which exactly corresponded to the number of
preadipocyte/macrophage-like cells found in semithin sections of
Nscl-2 mutant epididymale tissue (Fig. 5A, B). We also accessed
the size of adipocytes in wild type, Nscl-2 (2/2), ob/ob, and Nscl-
2( 2/2)6ob/ob compound mutant mice using flow cytometry.
We detected two groups of adipocytes: one small group with
adipocytes about 35 mm in diameter and a second group with
adipocytes larger than 100 mm. While virtually no small
adipocytes were found in the adipose tissue of wild type and ob/
ob mutant mice huge numbers of small cells were detected in Nscl-
2( 2/2) and Nscl-2 (2/2)6ob/ob compound mutant mice
resulting in a bimodal distribution of the size of adipocytes
(Fig. 6A).
To determine whether the high number of preadipocyte/
macrophage-like cells in Nscl-2 deficient mice resulted from cell
autonomous differentiation defects we isolated the stromal
vascular fraction (SVF) containing preadipocyte/macrophage-like
cells from WT (n=4) and Nscl-2 2/2 animals (n=3) and
subjected them to differentiation in vitro. Flow cytometry based
characterization of these cells revealed a general uniformity in cell
Figure 1. Reduced innervation and vascularization of WAT in Nscl-2 deficient mice. (A) Paraffin sections of WAT from wild-type (WT) and
Nscl-2 2/2 mice stained with an antibody against neurofilament (a–d) and peripherin (e, f). (a, b) sections through epididymal fat; (c–f) sections
through nerve fascicles within subcutaneous fat tissue. Scale bars in (a–d) 15 mm, in the small pictures in (c, d) 100 mm and in (e, f) 50 mm. (B)
Reduced vascularization of subcutaneous (SC) and epididymal (vis) fat tissue of Nscl-2 mutants. Immunostainings for endothelial cell markers CD31 (a,
b) and CD34 (c, d). Scale bars: 50 mm and in small pictures in (a, b) 15 mm. (C) Western blot analysis of CD34 protein expression in epididymal and
paired subcutaneous inguinal adipose tissue of wild-type and Nscl-2 knockout mice. Actin was used as a loading control. (D) Quantification of
Western blot analysis of CD34 protein expression in epididymal and paired subcutaneous inguinal adipose tissue of wild-type and Nscl-2 knockout
mice. Actin was used as a loading control.
doi:10.1371/journal.pone.0005516.g001
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confluent, cultured adipocytes were induced to differentiate by
addition of dexamethasone, insulin and IBMX. 9 days after
induction we counted the formation of mature adipocytes as
identified by oil red staining (Fig. 6C). Nscl-2 (2/2) adipocytes
differentiated readily giving rise to 56%612.5% oil red stained
cells as compared to 64%61.2% oil red stained WT cells
indicating a normal differential potential of Nscl-2 mutant
preadipocytes. No significant reduction of the expression of
PPARc, C/EBPa, C/EBPd and SREBP-1, which play decisive
roles in the differentiation of adipocytes [3], were detected in Nscl-
2 mutant epididymal adipose tissue although a slight reduction of
PPARc, C/EBPa in ob/ob and in Nscl-2 (2/2)6ob/ob
compound mutant mice was noted (Fig. 6D). Taken together
our results suggest that the cell differentiation potential of Nscl-2
mutant preadipocytes is not impaired.
Adipocytes from Nscl-2 mutant mice show increased
basal glucose uptake and lipolysis but decreased insulin
sensitivity
To study whether aberrant innervation and vascularization
caused by the lack of Nscl-2 had an impact on the metabolic
activity of WAT we investigated the glucose and/or lipid
metabolism of isolated adipocytes derived from Nscl-2 (2/2)
and Nscl-2 (2/2)6ob/ob compound mutant mice. Basal glucose
uptake in adipocytes from Nscl-2 (2/2), ob/ob, and double
mutant mice was significantly higher compared to wildtype
adipocytes (Fig 7A). However, stimulated glucose uptake (after
treatment with 80 nM insulin) was strongly mitigated in Nscl-2
(2/2) and ob/ob adipocytes compared to wildtype controls
indicating reduced insulin sensitivity (Fig. 7A). Analysis of glycerol
release revealed an increased basal level of lipolysis in Nscl-2 (2/
2), ob/ob, and double mutant adipocytes compared to wildtype
controls (Fig. 7B). Moreover, ß-adrenergic stimulation led to a
strong stimulation of lipolysis in Nscl-2 (2/2)6ob/ob compound
mutants, which was nearly twice as high as in control cells (Fig. 7B).
Inhibition of isoproterenol-stimulated glycerol release by insulin
resulted in a decrease of glycerol release of 56.4%613.9% in
wildtype, 29.9%610.5% in Nscl-2 deficient, 20.7%611.8% in
ob/ob adipocytes, and 35%68.8% in compound mutant
adipocytes again indicating an alleviation of the insulin resistance
in double mutant adipocytes. We also measured the metabolic
contribution of radioactively labeled glucose to lipogenesis
(incorporation into total triglycerides) under basal and insulin
stimulated conditions. Insulin treatment led to a better utilization
of glucose in all groups (Fig. 7C).
Figure 2. Reduced innervation of WAT in Nscl-2 deficient mice at different postnatal stages. Paraffin sections of WAT from wild-type (A,
C) and Nscl-2 2/2 mice (B, D) at 2 (A, B) and 6 month (C, D) of age stained with an antibody against peripherin. Sections were taken from epididymal
fat tissues. Note the reduction of peripherin positive nerves in Nscl-2 mutants. Scale bars 100 mm; in small pictures 15 mm.
doi:10.1371/journal.pone.0005516.g002
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in Nscl-2 (2/2) mice
The massive obesity of Nscl-2 mutant mice and the insulin
resistance of Nscl-2 deficient adipocytes suggested that Nscl-2
mutants might suffer from type II diabetes. Interestingly however,
the serum insulin levels of Nscl-2 mutant mice were virtually
normal while ob/ob mice, which are a model of Type II diabetes
[25], showed a massive increase in serum insulin concentrations
(Fig. 8A). Moreover, Nscl-2 (2/2)6ob/ob compound mutants
displayed a reduction of serum insulin concentration when
compared to ob/ob mice of the same age, sex and body weight
(Fig. 8A). While glucose tolerance tests did not show significant
differences between WT and Nscl-2 (2/2) mice (Fig. 8B) we
observed a reduced insulin sensitivity of Nscl-2 (2/2) mutant
mice in insulin tolerance tests. Injections of 1 U insulin/kg body
weight in wild type and Nscl-2 (2/2) animals caused a more
pronounced drop of glucose levels in wild type compared to
mutant animals 15, 30 and also 60 min after insulin treatment
(p,0.05, Fig. 8C).
The effect of the deletion of Nscl-2 on insulin action was further
characterized in a 2 h hyperinsulinemic-euglycemic clamp. We
detected a reduction of the steady state glucose infusion rate
required for maintenance of euglycemia in Nscl-2 (2/2) mice by
32% (Fig. 8D) confirming the insulin resistance of Nscl-2 deficient
mice. To measure time-dependent insulin-stimulated glucose
uptake into different tissues we injected a bolus of 100 mCi 2-
[1-
14(C)]-Deoxy-D-glucose at the end of the hyperinsulinemic-
euglycemic clamp. Glucose uptake of Nscl-2 mutant animals was
only reduced in adipose tissue but not in striated muscles. A
certain reduction was also noted in the heart although this result
Figure 3. Increased expression of leptin precedes abnormal gain of weight in Nscl-2 mutant mice. (A) Significant differences in the body
weight of WT and Nscl-2 (2/2) mice occur only post-puberty after 12–15 weeks of age (lower two graphs). Nscl-2 (2/2)6ob/ob and ob/ob mutant
mice show a similar increase of body weight during postnatal growth (upper two graphs). (B) Body weight of 6–8 month old Nscl-2 (2/2), Nscl-2 (2/
2)6ob/ob, ob/ob, and wild type male mice (F=53.33; dF=3; p,10
24). (C) Serum leptin levels are massively elevated in Nscl-2 (2/2) mice at 2, 4 and
6 month (F=11.91; dF=7; p,0.001). Note that the increase of serum levels of leptin in Nscl-2 mutant mice precedes the abnormal gain of weight. (D)
Serum adiponectin levels are elevated in Nscl-2 (2/2) mice at 2, and 4 month compared to wildtype control animals (F=13.53; dF=7; p,0.0001).
doi:10.1371/journal.pone.0005516.g003
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of WT mice (subcutaneous fat: 78%, epididymal fat: 70%;
p,0.01; Fig. 8E) [26,27].
Discussion
So far no clear link between peripheral nerve activity and
architecture and/or metabolic activity of adipose tissue had been
established although accumulating evidence suggested that
disturbed local interactions of peripheral nerves and adipose tissue
might affect the activity of adipocytes and the control of
preadipocyte differentiation [28]. Nscl-2 mutant mice show a
striking reduction of the innervation and vascularization of WAT,
which might lead to the increase of preadipocyte/macrophage-like
cells, the bimodal distribution of the size of adipocytes in WAT
and to the altered metabolic activity of adipocytes. We do not
believe that the elevated food intake and reduced physical activity
of Nscl-2 mutant mice is responsible for the WAT phenotype since
comparable changes have not been found in other models of
obesity, excessive food intake, and physical inactivity [29]. In
addition the changes in the architecture of WAT in Nscl-2
developed before the mutant became obese. Similarly, we
observed an increase of the serum concentrations of leptin and
adiponectin before Nscl-2 mutant mice gained excessive weight
clearly indicating that the changes in the architecture and/or
metabolic activity of adipose tissue were not directly caused by the
obesity, which develop later during life in Nscl-2 mutants.
Interestingly, the accumulation of preadipocytes is a rather
dominant phenotype, which prevailed even in Nscl-2/leptin
compound mutant mice indicating that leptin most probably is
not involved in this process. Currently, we favor the hypothesis
that the massive reduction of peripheral innervation and
vascularization in Nscl-2 mutant WAT is the primary cause for
metabolic changes in adipocytes and the morphological alterations
of the WAT. This statement is primarily supported by the
exclusive expression of Nscl-2 in the nervous system as well as by
the reduced innervation of WAT and increased release of
adipokines before puberty, preceding the onset of obesity.
However, we cannot completely exclude the possibility that other
host-derived signals contribute to the WAT phenotype. In fact, we
detected a marked elevation in the serum concentrations of
numerous adipokines such as leptin as well as resistin and
adiponectin, which might have an effect on the differentiation of
preadipocytes. The high leptin serum level result in an early leptin
resistance of Nscl-2 knockout mice. In particular resistin has been
described to inhibit preadipocyte differentiation in vitro [30] while
adiponectin promotes cell proliferation and differentiation from
preadipocytes into adipocytes [31]. The massive increase of the
concentration of various adipokines might enhance the heteroge-
neity of adipocytes and contribute to the accumulation of high
numbers of preadipocytes.
Currently, we do not know whether the massive reduction of
microvasculature in the WAT of Nscl-2 mutants contributes to the
phenotype. Although it is well known that the neuronal and the
vascular system share similar signaling cues, the concept of a
neurovascular link that recognizes the crosstalk between the
vascular and the nervous system is relatively new [21]. Nscl-2
Figure 4. Nscl-2 mutant mice show increased serum adiponec-
tin and resistin levels. (A) High serum adiponectin levels in adipose
Nscl-2 mutant mice. Adiponectin levels in 6–8 months old WT control
(n=4), Nscl-2 (2/2) (n=9), ob/ob (n=3), and Nscl-2 (2/2)6ob/ob
(n=1). (B) Increased serum resistin levels in Nscl-2 and Nscl-2/leptin
compound mutant mice. Serum resistin level were divided by body
weights of WT (n=23), Nscl-2 (2/2) (n=15), ob/ob (n=14) and Nscl-2
(2/2)6ob/ob mice (n=8). Asterisks indicate significant higher weight
matched serum resistin level in Nscl-2 (2/2) (F=6.3; dF=3; p,10
24).
(C) Serum resistin levels are inversely proportional to mRNA expression
of resistin in WAT (R
2=0.89; p=0.004). WT (n=2), Nscl-2 (2/2) (n=2),
ob/ob (n=2) and Nscl-2 (2/2)6ob/ob (n=2).
doi:10.1371/journal.pone.0005516.g004
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correlation between reduced innervation and reduction of
vascularization in the WAT.
The primary defect in Nscl-2 mutant mice lays in the nervous
system but not in adipose tissue. Yet, adipocytes isolated from
Nscl-2 mutant mice are insulin-resistant indicating that the
metabolic changes that develop in mutant mice led to a relatively
stable phenotype of adipocytes, which maintain these features in
vitro for some time. Although the serum concentration of insulin
was relatively low in Nscl-2 mutant mice, which argues against a
massive insulin resistance of insulin responsive cells, it is evident
that Nscl-2 mutant adipocytes have acquired properties in vivo
that led to an impaired glucose transport in vitro. The deficiency
of adipocytes was restricted to insulin stimulated glucose uptake
but did not affect the basal glucose uptake rate demonstrating that
the basic glucose uptake machinery was intact. It was surprising to
learn that Nscl-2 mutant mice show a normal glucose tolerance
and only a moderate decrease of insulin sensitivity despite the
insulin resistance of isolated adipocytes. This apparent paradox
questions the role of white adipose tissue in overall glucose
homeostasis [32]. Interestingly, mice with an adipose tissue specific
insulin receptor knockout (FIRKO mice) show a normal glucose
tolerance and insulin sensitivity and are protected against obesity-
related glucose intolerance [33], which resemble the Nscl-2
phenotype to certain degree. On the other hand, various
syndromes of lipodystrophy, insulin resistance associated with
obesity [34], and insulin resistance of mice with a fat-specific
knockout of GLUT4 [35] demonstrate an important role of fat
tissue in overall glucose homeostasis. Despite the important role of
adipocytes and WAT, the capacity of other tissues such as the
skeletal muscle to clear glucose seemed to compensate for the
impaired insulin response of adipocytes in Nscl-2 mutant mice.
The relative increase of adiponectin that we detected in Nscl-2
(2/2) mice might also contribute to improved insulin signalling in
non-adipose tissue and to normal serum glucose levels in vivo.
Such effects would be masked in tissue culture experiments where
isolated adiopocytes are analyzed. The increase in adiponectin
levels in Nscl-2 (2/2) mice was rather unexpected since
adiponectin levels are usually inversely correlated to percent body
fat resulting in the reduction of adiponectin concentrations in
obese animals (see [36] for a review). It is tempting to speculate
that the unusual morphology of WAT in Nscl-2 mutant mice,
which resulted from the accumulation of preadipocyte/macro-
phage-like cells and the bimodal distribution of the size of
adipocytes in WAT, was responsible for this surprising finding.
Taken together, we have uncovered a hitherto unknown
regulatory circuit that originates from the deficiency of the
neuron specific transcription factor Nscl-2 with consequences for
Figure 5. High number of preadipocyte/macrophage-like cells in the adipose tissue of Nscl-2 (2/2) and Nscl-2 (2/2)6ob/ob
compound mutant mice. (A) Number of preadipocyte/macrophage-like cells per 250 adipocytes (F=250.71; dF=3; p,10
24; 4 mice per group). (B)
Number of MOMA-2 positive but F4/80 negative cells per 250 adipocytes. The difference between MOMA-2 and F4/80 positive cells corresponds to
adipocyte precursors (p=0.038). (C) Richardson-stain of a section of epididymal adipose tissue from 6 months old male double mutant mouse. Arrow
indicates groups of preadipocyte/macrophage-like cells between fat cells (scale bar: 25 mm). (D) MOMA-2 staining of paraffin embedded epididymal
adipose tissue of a Nscl-2 (2/2) mouse (scale bar: 100 mm). The inlet shows a typical staining of MOMA-2 (scale bar: 15 mm).
doi:10.1371/journal.pone.0005516.g005
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preadipocytes in vivo. So far the effects of Nscl-2 on fat cell
metabolism had been solely explained by alterations in the
CNS. Although it is undisputable that the increased food intake
and reduced physical activity of Nscl-2 mutant mice are the
primary causes of adiposity in Nscl-2 mutant mice it now
becomes clear that Nscl-2 governs additional pathways that
affect the WAT. Fig. 9 summarizes our findings and presents a
putative model for the impact of Nscl-2 controlled mechanisms
on WAT.
Figure 6. Bimodal distribution of adipocytes in Nscl-2 (2/2) mice and normal in vitro differentiation of isolated Nscl-2 mutant
preadipocytes. (A) Semithin sections (Richardson stain) of epididymal adipose tissue from 6 month old male animals. Histograms indicate the size
distribution of isolated adipocytes from different strains. Scale bars: 100 mm. (B) FACS analysis (sideward versus forward scatter) of preadipocytes after
1 day in culture reveals a general uniformity in cell size and granularity. (C) Normal in vitro differentiation of isolated Nscl-2 mutant preadipocytes.
Differentiated, lipid drop containing cells were identified by oil red staining. (D) Relative mRNA expression level of adipocyte differentiation related
genes and adipocytokines expressed in epididymal WAT determined by quantitative Real-Time PCR (mean values, n$3). Values in bold indicate
changes .150% compared to controls, values in italic indicate changes ,50% of compared to controls. Relative expression level=(GeneX
mutant/
36B4
mutant)/ (GeneX
WT/36B4
WT).
doi:10.1371/journal.pone.0005516.g006
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PLoS ONE | www.plosone.org 8 May 2009 | Volume 4 | Issue 5 | e5516Figure 7. Impaired glucose metabolism and decreased insulin sensitivity in isolated adipocytes of Nscl-22/2, Nscl-22/26ob/ob
mice and controls. (A) Basal and insulin stimulated U-[
14C]glucose uptake in isolated adipocytes from 6 moth old male WT, ob/ob, Nscl-2 (2/2)
mice (n=4) and double mutant mice (n=3). Insulin stimulated glucose uptake was significant higher in all groups compared to basal levels
(p,0.005). a: significant difference between WT basal and basal of all others (F=28.17; dF=3; p,10
24), b: significant difference between insulin
stimulated glucose uptake by Nscl-2 2/2 and ob/ob versus WT and double mutant adipocytes (F=24.22; dF=3; p,10
24). (B) Lipolysis in isolated
adipocytes. Basal rates of lipolysis in the presence of 10 mM PIA (N6-[R-(-)-1-methyl-2-phenyl]adenosine) were compared to stimulated lipolysis in the
presence of 100 mM isoproterenol and to a treatment with 100 nM insulin, 15 min prior to the addition of 100 mM isoproterenol (WT: F=60.8; dF=2;
p,10
24. Nscl-2 (2/2): F=131.8; dF=2; p,10
24. ob/ob: F=97.1; dF=2; p,10
24. Nscl-2 (2/2)6ob/ob: F=212.1; dF=2; p,10
24). a: significant
difference of WT basal glycerol release versus basal level of all others (F=44; dF=3; p,10
24); b: significant difference of WT maximum glycerol
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PLoS ONE | www.plosone.org 9 May 2009 | Volume 4 | Issue 5 | e5516Figure 8. Metabolic parameters and insulin sensitivity in Nscl-2 2/2 and WT mice during hyperinsulinemic euglycemic clamp. (A) Ad
libitum serum insulin level measured at 9 am in WT controls (n=8), ob/ob mice (n=12), Nscl-2 mutants (n=3) and double mutants (n=3). (B) Glucose
tolerance test of 6 months old female WT and Nscl-2 (2/2) mice (n=4). (C) Insulin tolerance test. Means at 15, 30 and 60 minutes are significant
higher in Nscl-2 mutants compared to WT mice, (at 15 min: p=0.013; at 30 min: p=0.0014; at 60 min: p=0.017). (D) The glucose infusion rate during
a hyperinsulinemic-euglycemic clamp was decreased in Nscl-2 knockout mice compared to C57/Bl6 wild-type mice (n=6). (E) Insulin stimulated 2-
deoxyglucose uptake in vivo in different tissues during the clamp. Nscl-2 2/2 mice show specific insulin resistance in WAT (EPI: 70% reduction
(p=0.003); SC: 79% reduction (p=0.010).
release versus maximum release level of all others (F=32; dF=3; p,10
24); c: significant difference of WT 100 nM insulin+100 mM isoproterenol
stimulated glycerol release versus levels of all others (F=42; dF=3; p,10
24). (C) Glucose metabolism into triglycerides (TG) in isolated adipocytes at
5 mM glucose in the absence (basal) or presence of 80 nM insulin (asterisks indicate significant differences). a: significant difference between WT
basal and basal of all others (F=46.4; dF=3; p,10
24).
doi:10.1371/journal.pone.0005516.g007
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Ethics Statement
The investigation conforms to the Guide for the Care and Use of
Laboratory Animals published by the US National Institutes of
Health (NIH Publication No. 85-23, revised 1996) and was
approved by the local authorities of the state of Sachsen-Anhalt,
Germany as recommended by the responsible local animal ethics
review board.
Mice and metabolic studies
The generation of Nscl-2 knockout mice has been described
previously [13]. Nscl-2 knockout mice were backcrossed for .10
generation to C57BL/6J mice and maintained on the same
background. Six to eight weeks old heterozygous Nscl-2 (+/2)
mice bred to heterozygous C57BL/6J Lep
ob mice of purchased
from the Jackson Laboratory to generate double heterozygous
Nscl-2 (+/2)6ob/ob mice, which then were bred to generate
double mutants (Nscl-2 (2/2)6ob/ob). Because Nscl-2 (2/2)
and ob/ob mutants are infertile it was necessary to breed double
heterozygous mice to generate double mutant animals. If not
indicated otherwise at least 3 male animals at the age of 6 months
were used for all experiments. Isolation and analysis of adipocytes
have been described before [33], in brief animals were sacrificed,
and perigonadal fat pads were removed. Adipocytes were isolated
by collagenase (1 mg/ml) digestion. Aliquots of adipocytes were
fixed in 1% buffered osmium tetroxide and counted in a Coulter
counter to determine adipocyte size distribution and cell number
[37]. Determination of glucose transport, lipolysis and lipogenesis
of isolated adipocytes were done immediately after isolation as
described elsewhere [33]. For measurement of glucose transport
isolated adipocytes were stimulated for 30 min with 80 nM insulin
and incubated for 30 min with 3 mMU -
14C-glucose. Immediately
after the incubation adipocytes were fixed with osmic acid,
incubated for 48 hours at 37u and the radioactivity was quantified
after the cells had been decolorized. For analysis of lipolysis
isolated adipocytes (100 ml of a 10% isolated fat cell suspension)
were incubated in the presence of adenosine deaminase and
10 mM PIA (N6-[R-(-)-1-methyl-2-phenyl]adenosine) (basal), with
100 mM isoproterenol to produce maximal increase of lipolysis for
20 min and with 100 nM insulin, 15 min prior to the addition of
100 mM isoproterenol. Glycerol content of the incubation medium
was determined after 15 min using a radiometric assay as
previously described.
Figure 9. Putative model of the impact of Nscl-2 controlled mechanisms on WAT. The lack of Nscl-2 results in reduced innervation and
vascularization of WAT, which most likely leads to accumulation of preadipocyte/macrophage-like cells and the bimodal distribution of the size of
adipocytes in WAT. The altered functionality of adipocytes is reflected by decreased insulin sensitivity, increased basal glucose uptake, and increased
basal lipolysis. The decreased insulin sensitivity of isolated adipocytes seems to be compensated by other tissues, which might explain the relatively
normal serum insulin concentrations.
doi:10.1371/journal.pone.0005516.g009
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PLoS ONE | www.plosone.org 11 May 2009 | Volume 4 | Issue 5 | e5516Hyperinsulinemic-euglycemic clamp studies
Catheter implantation and hyperinsulinemic-euglycemic clamps
of 6 male and 6 female anesthetised mice at the age of 6 months
were performed as described previously [38,39]. Experiments were
started after an overnight fast. A 120-minute hyperinsulinemic-
euglycemic clamp was conducted with a continuous infusion of
human insulin at a rate of 20 mU/kg/min to raise plasma insulin
within a physiological range. Blood samples (20 mL) were collected
at 20- to 30-minute intervals for the immediate measurement of
plasma glucose concentration, and 20% glucose was infused at
variable rates to maintain plasma glucose at basal concentrations.
Insulin-stimulated whole-body glucose flux was estimated using a
prime-continuous infusion of HPLC-purified [3-
3H]glucose
(10 mCi bolus, 0.1 mCi/min; Perkin Elmer) throughout the
clamps. To estimate insulin-stimulated glucose transport activity
in individual tissues, 2-deoxy-D-[1-
14C]glucose (2-[
14C]DG;
Perkin Elmer) was administered as a bolus (10 mCi) 45 minutes
before the end of clamps. Blood samples (20 mL) were taken at 5,
10, 15, 25, 35 and 45 minutes after the 2-deoxy-D-glucose bolus
for the determination of plasma [
3H]glucose, and 2-[
14C]DG
concentrations. All infusions were done using microdialysis pumps
(TSE Systems). At the end of clamps several tissues were isolated
within a time limit of 5 minutes. Each tissue, once exposed, was
dissected out within 2 seconds, frozen immediately using liquid
N2-cooled aluminium blocks, and stored at 270uC for later
analysis. For the determination of plasma [3-
3H]glucose and 2-
[
14C]DG concentrations, plasma was deproteinized with ZnSO4
and Ba(OH)2, dried to remove [
3H]H2O, resuspended in water,
and counted in scintillation fluid (Perkin Elmer) on dual channels
for separation of
3H and
14C. For the determination of tissue 2-
[
14C]DG-6-phosphate (2-DG-6-P) content, tissue samples were
homogenized, and the supernatants were subjected to an ion-
exchange column to separate 2-DG-6-P from 2- DG.
Isolation of preadipocytes, flow cytometry, and in vitro
differentiation
Perigonadal fat pads were cut into small pieces and incubated at
37uC for 40 min with 1.5 mg/ml collagenase in isolation buffer
(123 mM NaCl, 5 mM KCl, 1.3 mM CaCl2, 5 mM Glucose,
100 mM HEPES, Pen/Strep, 4%BSA). After filtration through
100 mm nylonfilters predipocytes were collected by centrifugation
and incubated in erythrocyte lysis buffer (0.154 M NH4Cl, 0.01 M
KHCO3, 0.1 mM tetrasodium EDTA, pH 7.3) for 10 min at
room temperature. Preadipocytes were cultured in D-MEM:F12
(1:1) (Gibco) with10% FCS and antibiotics. Medium was changed
every second day. Differentiation was induced by adding 2 mg/ml
dexamethasone, 0.5 mM IBMX and 1 mM insulin for 48–
72 hours to the medium (DMEM high glucose from Gibco with
10% FCS), once the cells had reached confluency. After this
induction phase the cells were cultured for 48–72 hours in DMEM
with high glucose and 10% FCS with 1 mM insulin. Until day nine
after induction the cells were cultured with DMEM high glucose
medium with 10% FCS. Cells were fixed with 4% buffered
formaldehyde and lipid containing adipocytes were identified by
Oil Red O staining.
Histology, Immunocytochemistry and Western blot and
RNA analysis
Tissue embedding, sectioning, staining (Richardson-stain,
Fig. 5C, Fig. 6A) and immunocytochemistry of epididymal and
paired subcutaneous inguinal white adipose tissue were all
performed following standard procedures [33]. Immunocytochem-
istry was performed employing primary rat anti-mouse MOMA-2
and rat anti-mouse F4/80 antibodies (AbD Serotec), anti-human
neurofilament and CD31 (DAKO), rabbit anti-mouse peripherin
(DAKO) and CD34 antibodies (Cedar Springs). As secondary
antibodies HRP coupled anti-rat immunoglobulins (AbD Serotec)
and Envision dual link system-HRP (Dako) were used as described
previously. The specificity of all antibodies has been addressed
before [13 and unpublished observations]. For quantitative analysis
of MOMA-2 (macrophage and monocyte antibody-2; marker for
different macrophage stages and preadipocytes) positive but F4/80
(marker for mature macrophages but not preadipocytes) negative
cells, 10 adjacent MOMA-2 and F4/80 immunostained paraffin-
sections of different areas within the epididymal fat pad were
counted related to the number of 250 adipocytes. The difference
between MOMA- 2 and F4/80 positive cells was set as the number
of cells of the preadipocyte/macrophage-like lineage [40]. Western
blot analysis real time quantitative RT-PCR were performed as
described previously [13,41]. For isolationof total RNA and protein
from the tissue the Trizol Reagent (Invitrogen) was used. Protein
extracts were separated on 12% polyacrylamid gels and blotted on
nitrocellulose membrans using semidry blot technique. Membranes
were blocked in TBS-T buffer supplemented with 5% nonfat dry
milk for 1 hour at room temperature and incubated over night at 4
degree Celsius withanti-mouse CD 34 (Cedar Springs). Membranes
werewashedinTBS-Tbufferbeforeadditionofsecondaryantibody
(anti-mouse/rabbit Envision dual link system-HRP; DAKO).
Specific signals were visualized using ECL Advance Western
Blotting Detection Kit (GE Healthcare). For quantitative real time
PCR the following specific primer pairs were used to synthesize
DNA fragments from mouse fat tissue cDNA and for cloning into
pGem T-Vector (Promega), which were used in dilution series as
standards: Resistin: FW-59TCCAAATGCAATAAAGAACA39,
BW-59 GCAGAGCCACAGGAGCAG39; Adipsin: FW-59 GTG-
GCTGGTTGGGGTGTGGTCA39, BW-59 AAGTGTCCC-
TGCGGTTGCTCTC39; C/EBP-a: FW-59 GGGTGGAA-
CAGCTGAGCCGTGAACT39, BW-59 ATCCAGCGACCC-
GAAACCATCCTCT39; C/EBP-d: FW-59 AGCCCACTC-
CACCCACTT39, BW-59 CGACAACTCCACCAGCTTC39;
PPARc: FW-59 TGCGGAAGCCCTTTGGTGAC39, BW-59
CTTGGCGAACAGCTGAGAGGAC39; SREBP1: FW-59 CCA-
CATGGCGGGAGCACAC39, BW-59 GCCCAGCCGGATC-
TACACTATG39. 36B4 (Rplp0, ribosomal protein, large, P0), a
gene which expression is unaffected by adipogenesis and inflam-
mation, was used as normalization control.
Analytical procedures and statistical analysis
Serum leptin was measured using the mouse Leptin RIA Kit
(#ML-82K) from Linco Research. Serum insulin levels were
determined by ELISA using the Rat/Mouse Insulin Kit
(#EZRMI-13K, Linco Reasearch). Serum resistin and adiponec-
tin levels were measured with a Mouse Resistin ELISA Kit
(#EZMR-96K) by Linco Research and an adiponectin ELISA
Kit, respectively. Glucose and insulin tolerance tests were
performed as described previously [33]. All values are expressed
as mean6SE if not indicated otherwise. Comparison of means
between two groups was made using unpaired two-tailed Student’s
T-test and for more than two groups by analysis of variance
(ANOVA) followed by multicomparison Tuckey test. For ANOVA
analyses the F value, degrees of freedom (dF) and significance level
p are given. Significance was rejected at p$0.05 (*); p$0.01 (**).
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